Zevra Therapeutics Inc. (ZVRA)
NASDAQ: ZVRA
· Real-Time Price · USD
9.53
0.25 (2.69%)
At close: Aug 21, 2025, 10:13 AM
Zevra Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 47.71M | 37.34M | 33.78M | 54.04M | 39.26M | 42.85M | 43.05M | 43.27M | 66.2M | 40.18M | 65.47M | 70.06M | 76.78M | 100.24M | 112.35M | 131.5M | 132.29M | 75.92M |
Short-Term Investments | 154.9M | 25.29M | 35.71M | 35.34M | 10M | 9.87M | 24.69M | 40.16M | 21.18M | 55.1M | 17.38M | 5.83M | 4.2M | 1.34M | n/a | n/a | n/a | n/a |
Long-Term Investments | 15.09M | 6.09M | 6.01M | 6.11M | n/a | n/a | n/a | n/a | n/a | n/a | 20M | 31.46M | 33.53M | 17.56M | 15.42M | n/a | 400K | 400K |
Other Long-Term Assets | 1M | 10.91M | 11.38M | 9.27M | 11.07M | 14.21M | 9.94M | 629K | 599K | 673K | 724K | 1.03M | 1.22M | 437K | 438K | 439K | 37K | 37K |
Receivables | 18.27M | 12.62M | 10.51M | 7.79M | 8.95M | 8.3M | 17.38M | 9.93M | 14.03M | 7.82M | 8.3M | 6.58M | 2.82M | 3.32M | 1.53M | 1.62M | 1.89M | 11.31M |
Inventory | 1.11M | 2.56M | 1.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 577K | n/a | n/a | n/a | 930K | n/a | n/a | 109K |
Other Current Assets | 159.25M | 3.77M | 3.02M | n/a | n/a | n/a | n/a | 43.66M | n/a | 1.17M | -388K | n/a | n/a | n/a | -678K | n/a | n/a | n/a |
Total Current Assets | 226.34M | 81.57M | 86.03M | 99.44M | 60.89M | 62.89M | 86.94M | 137.01M | 103.43M | 104.28M | 93.02M | 85.13M | 87.44M | 105.78M | 115.06M | 134.63M | 136.18M | 87.73M |
Property-Plant & Equipment | 2.1M | 2.06M | 1.01M | 1.43M | 1.59M | 1.78M | 1.53M | 1.34M | 1.49M | 1.64M | 1.78M | 1.92M | 2.07M | 1.93M | 2.02M | 2.12M | 2.18M | 2.27M |
Goodwill & Intangibles | 11.75M | 72.08M | 73.69M | 75.31M | 70.86M | 72.4M | 73.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 29.94M | 91.14M | 92.1M | 92.11M | 83.52M | 88.39M | 85.39M | 1.97M | 2.09M | 2.31M | 22.51M | 34.42M | 36.82M | 19.93M | 17.89M | 2.56M | 2.62M | 2.71M |
Total Assets | 256.28M | 172.71M | 178.13M | 191.55M | 144.41M | 151.28M | 172.33M | 138.98M | 105.52M | 106.59M | 115.53M | 119.55M | 124.26M | 125.71M | 132.94M | 137.19M | 138.8M | 90.44M |
Account Payables | 15.84M | 17.82M | 13.07M | 24.46M | 20.45M | 22.79M | 13.99M | 13.08M | 10.51M | 10.1M | 3.61M | 4.28M | 3.6M | 2.58M | 516K | 2.08M | 2.97M | 2.75M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.71M | -10.1M | n/a | 2.83M | 1.8M | -2.58M | 2.52M | -2.08M | -2.97M | -2.85M |
Short-Term Debt | 525K | 589K | 420K | 540K | 596K | 583K | 37.7M | 435K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 683K |
Other Current Liabilities | 12.46M | 2.81M | 2.78M | 390K | 8.8M | 5.96M | 2.52M | -1.33M | 9.03M | 9.4M | 5.37M | 853K | 1.29M | 2.58M | -1.7M | 3.32M | 5.62M | 3.1M |
Total Current Liabilities | 28.83M | 26.98M | 34.06M | 34.48M | 30.45M | 29.91M | 73.72M | 21.71M | 18.25M | 15.62M | 12.02M | 8.43M | 7.16M | 2.94M | 4.23M | 3.7M | 5.96M | 4.24M |
Long-Term Debt | 61.75M | 60.09M | 59.5M | 58.9M | 58.33M | 43M | 5.07M | 43.87M | 12.71M | 12.91M | 12.8M | 12.8M | 12.8M | n/a | n/a | n/a | n/a | 98K |
Other Long-Term Liabilities | 48.46M | 43.46M | 44.52M | 27.91M | 22.61M | 28.85M | 31.22M | 5.41M | 5.43M | 5.92M | 14.55M | 3.57M | 3.98M | 114K | 355K | 420K | 762K | 334K |
Total Long-Term Liabilities | 110.22M | 104.71M | 104.4M | 87.3M | 81.48M | 72.56M | 36.74M | 49.8M | 18.77M | 19.57M | 28.2M | 17.33M | 17.87M | 1.26M | 1.59M | 1.75M | 2.17M | 1.95M |
Total Liabilities | 139.05M | 131.69M | 138.46M | 121.78M | 111.93M | 102.47M | 110.46M | 71.51M | 37.02M | 35.19M | 40.22M | 25.76M | 25.02M | 4.21M | 5.82M | 5.45M | 8.13M | 6.18M |
Total Debt | 62.28M | 61.84M | 60.3M | 59.93M | 59.47M | 44.29M | 43.77M | 44.82M | 13.79M | 14.12M | 14.13M | 14.23M | 14.35M | 1.51M | 1.61M | 1.71M | 1.75M | 2.75M |
Common Stock | 6K | 5K | 5K | 5K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 4K | 4K | 3K | 3K |
Retained Earnings | -433.68M | -508.39M | -505.29M | -469.55M | -436.32M | -416.4M | -399.78M | -339.47M | -325.42M | -320.34M | -353.73M | -299.55M | -292.94M | -268.89M | -267.03M | -264.33M | -262.57M | -268.77M |
Comprehensive Income | -2.43M | -82K | 631K | -115K | 421K | 141K | -43K | -220K | -225K | -63K | 113K | 201K | -0.00 | -0.00 | -0.00 | n/a | 0.00 | n/a |
Shareholders Equity | 117.23M | 41.02M | 39.67M | 69.77M | 32.48M | 48.82M | 61.86M | 67.47M | 68.5M | 71.4M | 75.12M | 93.79M | 99.23M | 121.5M | 127.12M | 131.74M | 130.66M | 84.25M |
Total Investments | 169.99M | 31.38M | 41.72M | 41.44M | 10M | 9.87M | 24.69M | 40.16M | 21.18M | 55.1M | 37.38M | 37.3M | 37.73M | 18.9M | 15.42M | n/a | 400K | 400K |